Enoxaparin Sodium Injection
Product Images NDC 68001-461

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Sodium Injection 30mg/0.3ml Carton (Carton 5601a)

The text contains some alphanumeric characters and scattered letters. However, it seems to be a list of medical products. The available information mentions "ENOXAPARIN SODIUM INJECTION" and "Single Dosa Syringes." The text also shows the amount of "30 mg". The provided text seems to be an incomplete document.*

FDA Label Image

Enoxaparin Sodium Injection 40mg/0.4ml Carton (Carton 5602a)

This is a description of a medication. The name of the medication is Enoxaparin Sodium Injection, which comes in a package of 10 single-dose syringes containing 40mg of the medication in each syringe. The medication is meant for subcutaneous injection only and must be stored at temperatures between 25°C and 30°C. The package contains instructions for use. The warning on the package advises to keep the medication out of the reach of children.*

FDA Label Image

Enoxaparin Sodium Injection 60mg/0.6ml Carton (Carton 5603a)

This is a description of a medication called Enoxaparin Sodium Injection for subcutaneous injection. The medication comes in single dose syringes containing 60mg of the injection per 0.1ml. The injection contains 80mg of sodium and the package includes instructions for use. The medication must be stored at 25°C and not be kept out of reach of children. The patient should call their doctor or medical advisor for advice on use and side effects. There is also a warning to keep the medicine out of reach of children.*

FDA Label Image

Enoxaparin Sodium 80mg/0.8ml Carton (Carton 5604a)

ENOXAPARIN SODIUM INJECTION is a medication for subcutaneous injection. It is derived from porcine intestinal tissue and contains 80mg of enoxaparin sodium in a single-dose syringe. The medication is used for thrombosis prevention and treatment in patients with conditions such as deep vein thrombosis or pulmonary embolism. It is recommended to consult a doctor or medical professional before using the medication and store it at controlled room temperature. The text also includes a warning to keep the product out of reach of children.*

FDA Label Image

Enoxaparin Sodium Injection 100mg/ml Carton (Carton 5605a)

ENOXAPARIN SODIUM INJECTION is a medication used for subcutaneous injection. Each milliliter contains 100 mg of noxaparin sodium derived from porcine intestinal mucosa. It is important to contact a doctor for advice on possible side effects, and it should be stored at a temperature of 2-8°C. This medication is available in single dose syringes of 25 mg. The text includes a warning to keep the medication out of the reach of children.*

FDA Label Image

Enoxaparin Sodium Injection 120mg/0.8ml Carton (Carton 5606a)

This description is for a medication called Enoxaparin Sodium Injection. It comes in single-dose syringes containing 120mg of the medication, which is derived from porcine intestinal mucosa. The medication is meant for subcutaneous injection and the package insert should be consulted for instructions on the proper use and administration. The medication should be stored at 25°C with permitted excursions.*

FDA Label Image

Enoxaparin Sodium Injection 150mg/ml Carton (Carton 5607a)

This is a description of a medication packaging for Enoxaparin Sodium Injection, used for subcutaneous injections. The package contains 10 single-dose syringes, with each 1 mL dosage measuring 150 mg of Enoxaparin Sodium. It provides storage instructions and cautions to keep it out of reach of children. The text also mentions a reference number and contact information to call for medical advice or in case of adverse effects.*

FDA Label Image

Enoxaparing Sodium Injection Usp Vial Carton (Carton 5608)

This is a description of a pharmaceutical product called Enoxaparin Sodium. It is an injection used for subcutaneous or intravenous administration. The solution contains 300 mg/3mL or 100 mg/mL of enoxaparin sodium, which is derived from porcine intestinal mucosa. The package insert should be consulted for dosage information and directions for use. The multiple-dose vial should not be stored for more than 28 days after the first use and should be kept away from children. The product is manufactured by Amphastar Pharmaceuticals in Rancho Cucamonga, California.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 00

This text seems to be describing a medical product called "Enoxaparin Sodium Injection Syringe" which comes with a needle cover. There is also a sharp disposal container included for safe disposal of the used syringe and needle.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 01

This text is already a description of the item "Protective Sleeve", which means it does not need any further description.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 02

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 03

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 04

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 05

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 06

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 07

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 08

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 09

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 10

Clear Liquid is a term used to describe a liquid substance that is transparent, without any visible particles or impurities. This type of liquid can include purified water, certain types of juices, broths, and some medications. It is commonly used in medical settings as a preparation for diagnostic tests, surgeries, or as a part of a cleansing process. Clear liquid diets are also recommended for those recovering from certain medical conditions or preparing for medical procedures.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 11

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 12

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 13

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 14

FDA Label Image

Instructions 1 (Enoxaparin 00)

FDA Label Image

Instructions 2 (Enoxaparin 01)

FDA Label Image

Instructions 3 (Enoxaparin 02)

FDA Label Image

Instructions 4 (Enoxaparin 03)

FDA Label Image

Instructions 5 (Enoxaparin 04)

FDA Label Image

Instructions 6 (Enoxaparin 05)

FDA Label Image

Chemical Structure (Enoxaparin 06)

FDA Label Image

Chemical Structure (Enoxaparin 07)

FDA Label Image

Figure 1 (Enoxaparin 08)

This is a table containing information about a medical study. The study gathered data on subgroups of patients separated by sex, age, infarct location, diabetes, prior MI, fibrinolytic agent, and time to treatment. The table shows the number of patients in each subgroup, the number of cardiac events (UFI), and the reduction in the risk of cardiac events with UFH treatment. The last row indicates that UFH (unfractionated heparin) is better than the alternative treatment, but it's unclear what the alternative treatment was.*

FDA Label Image

Figure 2 (Enoxaparin 09)

FDA Label Image

Enoxaparin Sodium Injection 30mg/ 0.3ml Syringe Label (Image 01)

FDA Label Image

Enoxaparin Sodium Injection 60mg/ 0.6ml (Image 02)

FDA Label Image

Enoxaparing Sodium Injection 40mg/0.4ml Syringe Label (Image 03)

This is a description of a medication named Enoxaparin Sodium Injection by Amphastar Pharmaceuticals. The injection is meant for subcutaneous use only, and each 0.4mL contains 40mg of the medication. There is a warning to keep the injection out of reach of children and caution to use only a proper syringe. The rest of the text is not readable.*

FDA Label Image

Enoxaparin Sodium Injection 80mg/ 0.8ml Syringe Label (Image 04)

FDA Label Image

Enoxaparin Sodium Injection 100mg/ml Syringe Label (Image 05)

This appears to be a mix of random letters, symbols, and phrases that do not form a coherent description. Therefore, it is not available.*

FDA Label Image

Enoxaparing Sodium Injection 120mg/ 0.8ml Syringe Label (Image 06)

FDA Label Image

Enoxaparin Sodium Injection 150mg/ml Syringe Label (Image 07)

FDA Label Image

Enoxaparin Sodium 300mg/3ml Vial Label (Image 08)

Enoxaparin Sodium is a prescription drug available as an injection in a 3 mL vial with a concentration of 100 mg/mL. The medication is intended for subcutaneous or intravenous use and must be stored at 20°C to 25°C. It is recommended not to use the same vial for more than 28 days. The drug is manufactured by Hastar Pharmaceuticals Inc. for BluePoint Laboratories.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.